Helicobacter pylori: gastric cancer and beyond
Open accessThe DOI matches its Crossref record; 142 of the 144 references it cites were found in a registry or an index.
Abstract
Helicobacter pylori is the dominant species of the human gastric microbiome, and colonization causes a persistent inflammatory response. H. pylori-induced gastritis is the strongest singular risk factor for cancers of the stomach; however, only a small proportion of infected individuals develop malignancy. Carcinogenic risk is modified by strain-specific bacterial components, host responses and/or specific host-microbe interactions. Delineation of bacterial and host mediators that augment gastric cancer risk has profound ramifications for both physicians and biomedical researchers as such findings will not only focus the prevention approaches that target H. pylori-infected human populations at increased risk for stomach cancer but will also provide mechanistic insights into inflammatory carcinomas that develop beyond the gastric niche.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“Similarly, some of these tested pathogens, such as E. coli and H. pylori, are known as initial causes of colon cancers [41,42].”
From Bioprophylactic potential of novel human colostrum probiotics via apoptotic induction of colon cancer cells and cell immune activation (2022) · cites this paper as [41]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“As a standout example, Helicobacter pylori infection is one of GC’s most important risk factors [95].”
From Bioinformatics Analysis and Validation of Potential Markers Associated with Prediction and Prognosis of Gastric Cancer (2024) · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lessons from hereditary colorectal cancer
Kinzler, K. W., & Vogelstein, B. (1996) · Cell · doi:10.1016/s0092-8674(00)81333-1 · Cited by 4,919
The complete genome sequence of the gastric pathogen Helicobacter pylori
Tomb, J.-F., White, O., Kerlavage, A. R., Clayton, R. A., Sutton, G. G., Fleischmann, R. D., Ketchum, K. A., Klenk, H. P., Gill, S., Dougherty, B. A., et al. (1997) · Nature · doi:10.1038/41483 · Cited by 3,529
Correa, P. (1992) · PubMed · Cited by 3,216
Alm, R. A., Ling, L.-S. L., Moir, D. T., King, B. L., Brown, E. D., Doig, P. C., Smith, D. R., Noonan, B., Guild, B. C., deJonge, B. L., et al. (1999) · Nature · doi:10.1038/16495 · Cited by 1,893
Helicobacter pylori and gastrointestinal tract adenocarcinomas
Peek, R. M., & Blaser, M. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc703 · Cited by 1,813 · cited 1×
“pylori strain that expressed lex and ley, only bacterial populations recovered from leb-positive mice expressed leb, and this was mediated by a putative galactosyltransferase gene (β‐(1,3)galT)38.”
BackgroundSelf-citationAn Essential Role for Ectodomain Shedding in Mammalian Development
Peschon, J. J., Slack, J. L., Reddy, P., Stocking, K. L., Sunnarborg, S. W., Lee, D. C., Russell, W. E., Castner, B. J., Johnson, R. S., Fitzner, J. N., et al. (1998) · Science · doi:10.1126/science.282.5392.1281 · Cited by 1,607 · cited 1×
“Furthermore, the processing and availability of at least three EGFR ligands, HBEGF, transforming growth factor-α ( TGFα ) and amphiregulin ( AREG ), requires ADAM17 expressio”
BackgroundPrenzel, N., Zwick, E., Daub, H., Leserer, M., Abraham, R., Wallasch, C., & Ullrich, A. (1999) · Nature · doi:10.1038/47260 · Cited by 1,504
Wong, B. C.-Y., Lam, S. K., Wong, W. M., Chen, J. S., Zheng, T. T., Feng, R. E., Lai, K. C., Hu, W. H. C., Yuen, S. T., Leung, S. Y., et al. (2004) · JAMA · doi:10.1001/jama.291.2.187 · Cited by 1,435 · cited 1×
“pylori significantly decreases the risk of developing cancer in infected individuals without pre-malignant lesion”
BackgroundTranslocation of Helicobacter pylori CagA into Gastric Epithelial Cells by Type IV Secretion
Odenbreit, S., Püls, J., Sedlmaier, B., Gerland, E., Fischer, W., & Haas, R. (2000) · Science · doi:10.1126/science.287.5457.1497 · Cited by 1,286 · cited 1×
“The product of the terminal gene in the island (CagA) is translocated into and phosphorylated within host epithelial cells following bacterial attachmen”
BackgroundNod1 responds to peptidoglycan delivered by the Helicobacter pylori cag pathogenicity island
Viala, J., Chaput, C., Boneca, I. G., Cardona, A., Girardin, S. E., Moran, A. P., Athman, R., Mémet, S., Huerre, M. R., Coyle, A. J., et al. (2004) · Nature Immunology · doi:10.1038/ni1131 · Cited by 1,226 · cited 1×
“, where they are sensed by an intracytoplasmic pathogen-recognition molecule nucleotide-binding oligomerization domain-containing protein 1 ( NOD1”
Background
Cited by
Items 401–500 of 1,000
Pachathundikandi, S. K., Blaser, N., & Backert, S. (2019) · Current topics in microbiology and immunology · doi:10.1007/978-3-030-15138-6_11 · Cited by 36
Salillas, S., Alías, M., Michel, V., Mahía, A., Lucía, A., Rodrigues, L., Bueno, J., Galano‐Frutos, J. J., Reuse, H. D., Velázquez‐Campoy, A., et al. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b00355 · Cited by 33
Guven‐Maiorov, E., Tsai, C., Ma, B., & Nussinov, R. (2017) · Journal of Molecular Biology · doi:10.1016/j.jmb.2017.10.023 · Cited by 32
“It causes persistent chronic inflammation and increases gastritis and gastric cancer risk [6].”
BackgroundAlbrecht, N., Tegtmeyer, N., Sticht, H., Skórko‐Glonek, J., & Backert, S. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00642 · Cited by 31
Pasala, C., Chilamakuri, C. S. R., Katari, S. K., Nalamolu, R. M., Bitla, A. R. R., & Umamaheswari, A. (2018) · Microbial Pathogenesis · doi:10.1016/j.micpath.2018.05.037 · Cited by 31
miR‐505 acts as a tumor suppressor in gastric cancer progression through targeting HMGB1
Tian, L., Wang, Z., Hao, J., & Zhang, X. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.28082 · Cited by 32
“In addition, another vital factor is associated with chronic inflammation in GC caused by Helicobacter pylori.(3) Recently, a lot of studies have revealed various mediators which are involved in GC.”
BackgroundCorral, J. E., Hurtado, J. J. D., Domínguez, R. L., de Cuéllar, M. V., Cruz, C. B., & Morgan, D. R. (2014) · Journal of Gastrointestinal Cancer · doi:10.1007/s12029-014-9672-1 · Cited by 31
“Gastric adenocarcinoma, in particular the intestinal subtype, is a multifactorial process, which progresses through a series of histopathology steps: normal mucosa, non-atrophic gastritis, multifocal atrophic gastritis, intestinal metaplasia, dysplasia, and adenocarcinoma [8].”
Chaturvedi, R., Asim, M., Barry, D. P., Frye, J., Casero, R. A., & Wilson, K. T. (2013) · Amino Acids · doi:10.1007/s00726-013-1531-z · Cited by 32
“Because spermine oxidase (SMO), which back-converts spermine to spermidine, is induced in macrophages by H. pylori, we determined its role in iNOS-dependent host defense.”
BackgroundCao, D., Jiang, J., You, L., Jia, Z., Tsukamoto, T., Cai, H., Wang, S., Hou, Z., Suo, Y.-E., & Cao, X. (2016) · BioMed Research International · doi:10.1155/2016/4943793 · Cited by 31
“Research Article”
Thorell, K., Hosseini, S., Gonzáles, R. V. P. P., Chaotham, C., Graham, D. Y., Paszat, L., Rabeneck, L., Lundin, S. B., Nookaew, I., & Sjöling, Å. (2016) · BMC Evolutionary Biology · doi:10.1186/s12862-016-0619-y · Cited by 31
“pylori has been linked to its virulence factors, mainly the vacuolating cytotoxin vacA and the Cag pathogenicity island, cagPAI [16, 17].”
BackgroundFlavodoxins as Novel Therapeutic Targets against Helicobacter pylori and Other Gastric Pathogens
Salillas, S., & Sancho, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051881 · Cited by 35
“The risk of developing Hp-related cancer has been suggested to depend on the Hp strain, the host traits, and the interactions between bacterium and host [9].”
BackgroundInfluence of microbiota on immunity and immunotherapy for gastric and esophageal cancers
Zhang, X., & Pan, Z. (2020) · Gastroenterology report · doi:10.1093/gastro/goaa014 · Cited by 32
“Both malignancies are very aggressive, with the 5-year survival rate in patients <20% [4, 5].”
BackgroundRen, L., Huang, D., Liu, H., Lin, N., Cai, P., Yu, X., Zhang, Y., Luo, N., Lin, H., Su, J., et al. (2024) · Oncology Letters · doi:10.3892/ol.2024.14285 · Cited by 31
“H. pylori infection, in particular, can progress from gastritis to gastroduodenal ulcers, gastric carcinoma and lymphoma (11).”
BackgroundLertsethtakarn, P., Howitt, M. R., Castellon, J., Amieva, M. R., & Ottemann, K. M. (2015) · Molecular Microbiology · doi:10.1111/mmi.13086 · Cited by 30
“pylori infection results in ulcers and gastric cancer and affects millions worldwide (Polk and Peek, 2010; Salama et al., 2013).”
BackgroundVaziri, F., Peerayeh, S. N., Alebouyeh, M., Molaei, M., Maghsoudi, N., & Zali, M. R. (2013) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2013.03.048 · Cited by 30
Luo, C., Sun, F., Zhu, H., Ni, Y., Fang, J., Liu, Y., Shao, S., Shen, H., & Hu, J. (2017) · Pathology - Research and Practice · doi:10.1016/j.prp.2017.08.009 · Cited by 33
Chuang, C., Yang, H.-B., Sheu, S., HUNG, K. ‐., Wu, J., Cheng, H.-C., Chang, W.-L., & Sheu, B. (2011) · BMC Microbiology · doi:10.1186/1471-2180-11-121 · Cited by 30
“pylori-infected host has an increased risk of developing gastric cancer, once the gastric histology reveals a corpus-predominant pattern or a precancerous change such as IM [30-33].”
BackgroundKang, H., Lim, J. W., & Kim, H. (2018) · Journal of Ginseng Research · doi:10.1016/j.jgr.2018.08.003 · Cited by 30
“pylori infection disorganizes the gastric epithelial architecture by inducing apoptosis and accumulating DNA-damaged cells [4,5].”
BackgroundChen, Y., Wang, X., Yu, Y., Xiao, Y., Huang, J., Yao, Z., Chen, X., Zhou, T., Li, P., & Xu, C. (2018) · Clinical & Experimental Immunology · doi:10.1111/cei.13200 · Cited by 32
Loss of MTUS1 in gastric cancer promotes tumor growth and metastasis
Li, X., Liu, H., Yu, T., Dong, Z., Tang, L., & Sun, X. (2013) · Neoplasma · doi:10.4149/neo_2014_018 · Cited by 30
Inflammation and proliferation – a causal event of host response to Helicobacter pylori infection
Subhash, V. V., & Ho, B. (2015) · Microbiology · doi:10.1099/mic.0.000066 · Cited by 31
Helicobacter pylorivirulence factors affecting gastric proton pump expression and acid secretion
Hammond, C. E., Beeson, C., Suárez, G., Peek, R. M., Backert, S., & Smolka, A. J. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00099.2015 · Cited by 29
“HUMAN GASTRIC COLONIZATION by the Gram-negative bacterium Helicobacter pylori causes chronic active gastritis that may progress to peptic ulcer disease, gastric mucosa-associated lymphoid tissue lymphoma, and gastric adenocarcinoma (40).”
BackgroundSelf-citationWang, W., Li, Z., Wang, J., Du, M., Li, B., Zhang, L., Li, Q., Xu, J., Wang, L., Li, F., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.31197 · Cited by 29
Fang, W., Huang, K., Chang, S., Lin, C., Chen, M., Chao, Y., Lo, S.-S., Li, A. F., Wu, C.-W., & Shyr, Y. (2019) · The Oncologist · doi:10.1634/theoncologist.2018-0742 · Cited by 29
“Chronic gastritis initiated with HP infection can lead to atrophic gastritis, intestinal metaplasia, and finally to dysplasia and adenocarcinoma [3].”
BackgroundAssociation of Helicobacter pylori babA2 gene and gastric cancer risk: a meta-analysis
Kpoghomou, M.-A., Wang, J., Wang, T., & Jin, G. (2020) · BMC Cancer · doi:10.1186/s12885-020-06962-7 · Cited by 29
Kadeerhan, G., Gerhard, M., Gao, J., Mejías‐Luque, R., Zhang, L., Vieth, M. W., Ma, J., Bajbouj, M., Suchánek, Š., Liu, W., et al. (2021) · PubMed · Cited by 34
DUB1 suppresses Hippo signaling by modulating TAZ protein expression in gastric cancer
Wang, D., Li, Z., Li, X., Yan, C., Yang, H., Zhuang, T., Wang, X., Zang, Y., Liu, Z., Wang, T., et al. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02410-5 · Cited by 29
“Several biomedical studies have shown the involvement of Helicobacter pylori infection and chronic inflammation in gastric cancer development [5]; however, the detailed mechanisms underlying gastric cancer progression are still unclear.”
BackgroundZhou, C., Bisseling, T. M., van der Post, R. S., & Boleij, A. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.11.053 · Cited by 33
“Compositional changes in gastric mucosal microbiota have been associated with an increased risk of GC, but also with the development of other gastric diseases [8,9].”
BackgroundYang, W., Chen, L., Li, H., Li, B., Hu, J., Zhang, J., Yang, S., Zou, Q., Guo, H. Y., & Wu, C. (2013) · Vaccine · doi:10.1016/j.vaccine.2012.12.058 · Cited by 29
“The infection has been causally linked o chronic gastritis, peptic ulcer disease, gastric adenocarcinoma nd gastric mucosa-associated lymphoid tissue lymphoma [3,4].”
BackgroundSerum carbohydrate antigen 19-9 and prognosis of patients with gastric cancer
Xiao, J., He, X., Wang, Z., Hu, J., Sun, F., Qi, F., Yang, S., & Xiao, Z. (2013) · Tumor Biology · doi:10.1007/s13277-013-1177-1 · Cited by 29
Fragmentation of CagA Reduces Hummingbird Phenotype Induction by Helicobactor pylori
Chang, C.-C., Kuo, W.-S., Chen, Y.-C., Perng, C., Lin, H., & Ou, Y.-H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0150061 · Cited by 29
Genetic features of multicentric/multifocal intramucosal gastric carcinoma
Mizuguchi, A., Takai, A., Shimizu, T., Matsumoto, T., Kumagai, K., Miyamoto, S., Seno, H., & Marusawa, H. (2018) · International Journal of Cancer · doi:10.1002/ijc.31578 · Cited by 30
Teng, Y., Xie, R., Xu, J., Wang, P., Chen, W., Shan, Z., Yan, Z., Mao, F., Cheng, P., Peng, L., et al. (2023) · Cellular and Molecular Immunology · doi:10.1038/s41423-023-01055-4 · Cited by 29
“pylori) is a human pathogen that has infected nearly half of the world’s population [1, 2].”
BackgroundKhazaei, S., Rezaeian, S., Khazaei, Z., Molaeipoor, L., Nematollahi, S., Lak, P., & Khazaei, S. (2016) · Advances in Breast Cancer Research · doi:10.4236/abcr.2016.51003 · Cited by 28
“However, this type of cancer along with cancers caused by infectious agents is considered among highest health problems in these regions by other authors [17] [18].”
BackgroundFang, X., Xu, J., Jin, K., & Qian, J. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.110062 · Cited by 29
G‐A variant in miR‐200c binding site of EFNA1 alters susceptibility to gastric cancer
Li, Y., Nie, Y., Cao, J., Tu, S., Lin, Y., Du, Y., & Li, Y. (2012) · Molecular Carcinogenesis · doi:10.1002/mc.21966 · Cited by 31
“Helicobacter pylori infection is the strongest risk factor for GC [2], but only a small proportion of infected individuals develop malignancy.”
BackgroundInnate Immune Responses to Helicobacter pylori Infection: An Overview
Patel, M. K., Trombly, M. I., & Kurt‐Jones, E. A. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-005-2_23 · Cited by 28
Mechanisms linking metabolism of Helicobacter pylori to 18O and 13C-isotopes of human breath CO2
Som, S., De, A., Banik, G. D., Maity, A., Ghosh, C., Pal, M., Daschakraborty, S. B., Chaudhuri, S., Jana, S., & Pradhan, M. (2015) · Scientific Reports · doi:10.1038/srep10936 · Cited by 28
Helicobacter pyloriγ-glutamyl transpeptidase: A formidable virulence factor
Ling, S. S. M., Yeoh, K. G., & Ho, B. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i45.8203 · Cited by 27
Tozzi, M., Fiore, A., Travaglione, S., Marcon, F., Rainaldi, G., Germinario, E. A. P., Laterza, I., Donati, S., Macchia, D., Spada, M., et al. (2025) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-03271-w · Cited by 27
“This is the case of Helicobacter pylori infection associated with gastric cancer [10], and of Campylobacter jejuni and Salmonella typhi infection, associated with small intestinal lymphomas and hepatobiliary carcinoma respectively [11].”
Regulation ofHelicobacter pyloriVirulence Within the Context of Iron Deficiency
Noto, J. M., Lee, J. Y., Gaddy, J. A., Cover, T. L., Amieva, M. R., & Peek, R. M. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu805 · Cited by 27
“pylori strains harboring the cag pathogenicity island further augment cancer risk [1].”
BackgroundSelf-citationBacterial cyclomodulins: types and roles in carcinogenesis
Morgan, R. N., Saleh, S. E., Farrag, H. A., & Aboulwafa, M. (2021) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2021.1944052 · Cited by 34
“…century and the beginning of the twentieth, the possibility that bacterial infections contribute to carcinogenesis was presumed following the discovery of experimental evidences linking Helicobacter pylori infection with gastric carcinoma and MALT lymphoma (Mager 2006; Polk and Peek 2010).”
BackgroundInfluentialRole of Helicobacter pylori in Gastric Carcinoma: A Review
Kesharwani, A., Dighe, O. R., & Lamture, Y. R. (2023) · Cureus · doi:10.7759/cureus.37205 · Cited by 27
“pylori is the most abundant bacterium in the stomach microbiota, accounting for 40 to 90 percent of the total [2-3].”
BackgroundThe Prevalence ofHelicobacter pyloriInfection Decreases with Older Age in Atrophic Gastritis
Chen, S., Ying, L., Kong, M., Zhang, Y., & Li, Y. (2013) · Gastroenterology Research and Practice · doi:10.1155/2013/494783 · Cited by 27
“pylori-infected individuals develop cancer of the stomach [2].”
BackgroundCD14 regulates gastric cancer cell epithelial-mesenchymal transition and invasion in vitro
Li, K., DAN, Z., Hu, X., Gesang, L., Ze, Y., & BIANBA, Z. (2013) · Oncology Reports · doi:10.3892/or.2013.2733 · Cited by 27
Molecular Pathogenesis of Helicobacter pylori-Related Gastric Cancer
Shimizu, T., Marusawa, H., Watanabe, N., & Chiba, T. (2015) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2015.05.011 · Cited by 27
Pinto-Ribeiro, I., Ferreira, R. M., Batalha, S., Hlaing, T., Wong, S. I., Carneiro, F., & Figueiredo, C. (2016) · Toxins · doi:10.3390/toxins8050142 · Cited by 27
“The major risk factor for the development of gastric carcinoma is persistent Helicobacter pylori infection [2].”
BackgroundSom, S., Banik, G. D., Maity, A., Chaudhuri, S., & Pradhan, M. (2017) · Journal of Breath Research · doi:10.1088/1752-7163/aa8efb · Cited by 27
Regulation of β-catenin by t-DARPP in upper gastrointestinal cancer cells
Vangamudi, B., Zhu, S., Soutto, M., Belkhiri, A., & El-Rifai, W. M. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-32 · Cited by 30
“The biology of gastrointestinal cancer involves complex signaling mechanisms and critical molecular interactions, most of which remain uncharacterized [7-9].”
BackgroundXu, C., Sun, X., Jin, M., & Zhang, X. (2017) · Marine Drugs · doi:10.3390/md15070200 · Cited by 26
“In order to evaluate the roles of these functional groups in their function, two derivatives of 2-amino-6-hydroxy-[1,4]-benzoquinone”
BackgroundInfluentialKim, J., Kim, H., Lee, J., Choi, I. J., Kim, J., & Kim, J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2020.596355 · Cited by 26
“pylori strains produce various cytotoxins, such as Cag-A, which can damage gastric mucosal cell membranes and trigger local immune responses (74).”
Lam, S. Y., Mommersteeg, M. C., Yu, B., Broer, L., Spaander, M. C. W., Frost, F., Weiss, S., Völzke, H., Lerch, M. M., Schöttker, B., et al. (2022) · Gastroenterology · doi:10.1053/j.gastro.2022.01.011 · Cited by 26
Kumagai, K., Shimizu, T., Takai, A., Kakiuchi, N., Takeuchi, Y., Hirano, T., Takeda, H., Mizuguchi, A., Teramura, M., Ito, T., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-21-1523 · Cited by 28
Tran, L. S., Ying, L., D’Costa, K., Wray‐McCann, G., Kerr, G., Le, L., Allison, C. C., Ferrand, J., Chaudhry, H., Emery, J., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-39487-1 · Cited by 27
Yamamichi, N., Hirano, C., Shimamoto, T., Minatsuki, C., Takahashi, Y., Nakayama, C., Matsuda, R., Fujishiro, M., Konno‐Shimizu, M., Kato, J., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0111359 · Cited by 26
“pylori infection mostly causes pathological gastritis with mucosal atrophy and precancerous intestinal metaplasia [16,17,18,19,20].”
BackgroundJin, X., Hu, X.-R., Wang, Q., Wang, K., Yao, Q. Z., Tang, G., & Chu, P. K.-H. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2013.12.040 · Cited by 26
Yamamichi, N., Hirano, C., Takahashi, Y., Minatsuki, C., Nakayama, C., Matsuda, R., Shimamoto, T., Takeuchi, C., Kodashima, S., Ono, S., et al. (2015) · Gastric Cancer · doi:10.1007/s10120-015-0515-y · Cited by 26
A lucid review of Helicobacter pylori ‐induced DNA damage in gastric cancer
Fu, L. S., & Xie, C. (2019) · Helicobacter · doi:10.1111/hel.12631 · Cited by 28
Simawaranon, T., Wattanawongdon, W., Tongtawee, T., Paoin, C., Kangwantas, K., & Dechsukhum, C. (2020) · BioMed Research International · doi:10.1155/2020/7243029 · Cited by 26
Syrios, J., Sougioultzis, S., Xynos, I. D., Kavantzas, N., Kosmas, C., Agrogiannis, G. D., Grınıatsos, J., Karavokyros, I., Pikoulis, E. A., Patsouris, E., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-264 · Cited by 25
“There is considerable evidence to support causality between HP and sporadic noncardia gastric cancer [22].”
BackgroundUsefulness of aHelicobacter pyloristool antigen test for diagnosingH. pyloriinfected C57BL/6 mice
Moon, D.-I., Shin, E.-H., Oh, H., Oh, J. H. O., Hong, S., Chung, Y.-H., & Kim, O. (2013) · Laboratory Animal Research · doi:10.5625/lar.2013.29.1.27 · Cited by 25
“pylori in 1983, it has become one of the most common bacterial pathogens in humans causing chronic gastritis and peptic ulcer disease and is associated with gastric adenocarcinoma [7,8].”
BackgroundSmith, S. M., Freeley, M., Moynagh, P. N., & Kelleher, D. P. (2016) · Helicobacter · doi:10.1111/hel.12325 · Cited by 25
Eight pillars of oncorheumatology: Crossroads between malignancies and musculoskeletal diseases
Szekanecz, Z., Gomez, I., Soós, B., Bodoki, L., Szamosi, S., András, C., Juhász, B., Váróczy, L., Antal‐Szalmás, P., Szodoray, P., et al. (2020) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102658 · Cited by 26
Noori, M., Mahboobi, R., Nabavi-Rad, A., Jamshidizadeh, S., Fakharian, F., Yadegar, A., & Zali, M. R. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e19607 · Cited by 25
“H. pylori specifically colonizes the gastric epithelium and usually persists for decades, developing a dynamic and persistent equilibrium with its human host [1].”
BackgroundKumar, S., & Dhiman, M. (2024) · Cellular Immunology · doi:10.1016/j.cellimm.2024.104811 · Cited by 29
Shu, X., Yang, Z., Li, Z., Chen, L., Zhou, X., Xie, Y., & Lü, N. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3470-2 · Cited by 25
“pylori infection is one of the greatest risk factors for the development of many upper gastrointestinal diseases, including gastric inflammation (gastritis), gastric and duodenal ulcers, gastric cancer (GC), and gastric mucosaassociated lymphoid tissue (MALT) lymphoma [1, 2].”
BackgroundBehnampour, N., Hajizadeh, E., Zayeri, F., & Semnani, S. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.3.1111 · Cited by 25
Ngo, H., Lee, H. G., Piao, J., Zhong, X., Lee, H., Han, H., Kim, W.-K., Kim, D., Cha, Y., Na, H., et al. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22464 · Cited by 25
“bacterium, infects approximately half of the world’s population, possibly reaching up to 70% in developing countries and 20–30% in industrialized nations [1].”
BackgroundChen, G., Shu, Y.-C., Chuang, D., & Wang, Y.-C. (2016) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x1650066x · Cited by 25
Zhang, Z., Huang, Q., Tao, X., Song, G., Zheng, P., Li, H., Sun, H., & Xia, W. T. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007387 · Cited by 25
“Helicobacter pylori, a Gram-negative microaerophilic bacterium that colonizes the human stomach and is the leading cause of human gastric disease, such as peptic ulcers, gastritis, and even gastric cancer (4), produces a series of virulence factors, e.”
BackgroundȘurlin, P., Nicolae, F. M., Şurlin, V., Pătrașcu, Ș., Ungureanu, B. S., Didilescu, A. C., & Gheonea, D. I. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123885 · Cited by 26
Srikham, K., & Thirabunyanon, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112871 · Cited by 24
Modeling cancer–microbiome interactions in vitro: A guide to co‐culture platforms
Moskal, K., Khurana, N., Siegert, L., Lee, Y., Clevers, H. C., Elinav, E., & Puschhof, J. (2024) · International Journal of Cancer · doi:10.1002/ijc.35298 · Cited by 25
“10 Helicobacter pylori was reported to induce inflammation, modulate immune responses and activate the Wnt/ β -catenin signaling pathway as some mechanisms of promoting gastric carcinogenesis 11 and is classified as class-1 carcinogen by IARC/WHO.”
Potential utility of nano-based treatment approaches to address the risk of Helicobacter pylori
Khan, S., Sharaf, M., Ahmed, I., Khan, T. U., Shabana, S., Arif, M., Kazmi, S. S. U. H., & Liu, C. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2022.1990041 · Cited by 27
Potential Therapeutic Effects of Egg Yolk Antibody (IgY) in Helicobacter pylori Infections─A Review
Zhang, L., Xiao, Y., Ji, L., Lin, M., Zou, Y., Zhao, J., & Zhao, S. (2021) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.1c05398 · Cited by 24
Targeting Hippo pathway: A novel strategy for Helicobacter pylori-induced gastric cancer treatment
Liu, Y., Zhang, B., Zhou, Y., Xing, Y., Wang, Y., Jia, Y., & Liu, D. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114549 · Cited by 25
Ahmadzadeh, A., Ghalehnoei, H., Farzi, N., Yadegar, A., Alebouyeh, M., Aghdaei, H. A., Molaei, M., Zali, M. R., & Gholi, M. A. P. H. (2015) · Pathologie Biologie · doi:10.1016/j.patbio.2015.09.004 · Cited by 25
Campisano, F., Gramuglia, F., Dawson, I. R., Lyne, C. T., Izmaylov, M. L., Misra, S., Momi, E. D., Morgan, D. R., Obstein, K. L., & Valdastri, P. (2017) · IEEE Robotics & Automation Magazine · doi:10.1109/mra.2017.2673852 · Cited by 24
“Gastric adenocarcinoma is a multifactorial process that progresses through a series of histopathology stages: normal mucosa, nonatrophic gastritis, multifocal chronic atrophic gastritis (CAG), intestinal metaplasia (IM), and, finally, dysplasia and adenocarcinoma [6], [7].”
BackgroundFeng, G., Chen, Y., & Li, K. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29826 · Cited by 24
Microbe-Driven Genotoxicity in Gastrointestinal Carcinogenesis
Hartl, K., & Sigal, M. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21207439 · Cited by 25
Sawada, A., Fujiwara, Y., Nagami, Y., Tanaka, F., Yamagami, H., Tanigawa, T., Shiba, M., Tominaga, K., Watanabe, T., Gi, M., et al. (2016) · Digestive Diseases and Sciences · doi:10.1007/s10620-016-4263-6 · Cited by 24
“Several studies showed that Helicobacter pylori in gastric cancer [28] and pks Escherichia coli and Fusobacterium nucleatum in colorectal cancer are associated with GI tract tumorigenesis [29, 30].”
ResultHelicobacter pylori attachment-blocking antibodies protect against duodenal ulcer diseasePreprint
Bugaytsova, J. A., Moonens, K., Piddubnyi, A., Schmidt, A., Edlund, J. O., Lisіutin, G. V., Brännström, K., Chernov, Y. A., Thorell, K., Tkachenko, I., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.24.542096 · Cited by 24
Hadi, H. I., Aljanaby, A. A. J., & Enaya, M. A. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns2.5134 · Cited by 23
“…the cag pathogenicity island (PAI) is a well-studied and well-characterized virulence determinant of H.pylori; strains containing the cag PAI are associated with a higher risk of distal gastric cancer than those strains lacking this virulence factor (Amieva and El– Omar, 2008; Polk and Peek, 2010).”
BackgroundInnate Immunity in Helicobacter pylori Infection and Gastric Oncogenesis
Zhang, Y., Yan, Z., Jiao, Y., Feng, Y., Zhang, S., & Yang, A. (2025) · Helicobacter · doi:10.1111/hel.70015 · Cited by 25
“It regulates the local inflammatory response initiated by H. pylori infection, which can cause tissue damage, by preventing the prolonged release of inflammatory mediators and ROS associated with carcinogenesis [93, 96].”
Chen, Y., Huang, J., Li, H., Li, P., & Xu, C. (2020) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107012 · Cited by 23
Li, Y., Li, T., Chen, J., Zheng, H., Li, Y., Chu, F., Wang, S., Li, P., Lin, J., Su, Z., et al. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.927731 · Cited by 23
Microbiota-Derived Natural Products Targeting Cancer Stem Cells: Inside the Gut Pharma Factory
Artusa, V., Calabrone, L., Mortara, L., Peri, F., & Bruno, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054997 · Cited by 24
Liu, Y., Cao, J., Yang, Q. E., Zhu, L., Zhao, W., Wang, X., Yao, J., Zhou, Y. C., & Shao, S. (2023) · Biology Direct · doi:10.1186/s13062-023-00402-9 · Cited by 23
“HP was classified as a class I carcinogen by WHO in 1994 [25, 26] and a definite carcinogen by the United States in December 2021.”
BackgroundBacteria-targeted biomaterials: Glycan-coated microspheres to bind Helicobacter pylori
Gonçalves, I. C., Magalhães, A., Costa, A. M. S., de Oliveira, J. R., Henriques, P. C., Gomes, P. A. C., Reis, C. A., & Martins, M. C. L. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2016.01.029 · Cited by 23
“Chronic infection by this bacterium has been associated with several gastric complications such as gastritis, peptic ulcer and gastric carcinoma [2].”
BackgroundVaziri, F., Peerayeh, S. N., Alebouyeh, M., Maghsoudi, N., Azimzadeh, P., Siadat, S. D., & Zali, M. R. (2014) · Pathogens and Disease · doi:10.1093/femspd/ftu021 · Cited by 23
Shen, H., Li, L., Chen, Q., He, Y., Yu, C., Chu, C., Lu, X., & Chen, J. (2016) · Genetics and Molecular Research · doi:10.4238/gmr15048889 · Cited by 23
TFF1 antagonizes TIMP‐1 mediated proliferative functions in gastric cancer
Omar, O. M., Soutto, M., Bhat, N. S., Bhat, A. A., Lu, H., Chen, Z., & El-Rifai, W. M. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22880 · Cited by 23
“classification, is the primary risk factor.(3) However, according to population-based prospective studies, diet-related risk factors, such”
BackgroundMeliţ, L. E., Săsăran, M. O., Mocan, S. L., & Mărginean, C. O. (2019) · Medicine · doi:10.1097/md.0000000000016188 · Cited by 23
Studying the effects of several heat-inactivated bacteria on colon and breast cancer cells.
Rabiei, P., Mohabatkar, H., & Behbahani, M. (2019) · PubMed Central · doi:10.22099/mbrc.2019.33958.1413 · Cited by 26
“The results showed that the Helicobacter pylori infection is one of the first-class carcinogens and is a very important agent in gastric cancer and mucosaassociated lymphoid tissue (MALT) lymphoma [4-7].”
ResultArmando Rojas, R., González, I., Rodríguez, B. L., Romero, J. A., Figueroa, H., Jorge Llanos, L., Morales, E., & Pérez-Castro, R. (2011) · Microbes and Infection · doi:10.1016/j.micinf.2011.04.005 · Cited by 23
Zeng, Z., Sun, Y., Jiang, J., Xu, X., Lin, H.-X., Li, W., Zheng, D., Huang, Y., & Zhao, C. (2024) · Biomaterials · doi:10.1016/j.biomaterials.2024.122672 · Cited by 22
Geospatial analyses identify regional hot spots of diffuse gastric cancer in rural Central America
Domínguez, R. L., Cherry, C. B., Estevez-Ordonez, D., Mera, R. M., Escamilla, V., Pawlita, M., Waterboer, T., Wilson, K. T., Peek, R. M., Tavera, G., et al. (2019) · BMC Cancer · doi:10.1186/s12885-019-5726-x · Cited by 22
Self-citationProphylactic immunization to Helicobacter pylori infection using spore vectored vaccines
Katsande, P. M., Nguyễn, V. D., Nguyen, T. L. P., Nguyen, T. K. C., Mills, G., Bailey, D. M., Christie, G., Hong, H. A., & Cutting, S. M. (2023) · Helicobacter · doi:10.1111/hel.12997 · Cited by 23
Rayan, M., Sayed, T. S., Hussein, O., Therachiyil, L., Maayah, Z. H., Maccalli, C., Shahab Uddin, M. S., Prehn, J. H. M., & Korashy, H. M. (2024) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-024-00538-0 · Cited by 22
“Further analysis revealed that several genes of Helicobacter pylori alter tissue homeostasis, leading to the accumulation of cytokines and activation of other cancer-causing signaling, such as the β-catenin signaling pathway [65, 68].”
BackgroundLiu, Z., Demitrack, E. S., Keeley, T. M., Eaton, K. A., Zaatari, M. E., Merchant, J. L., & Samuelson, L. C. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.73 · Cited by 22
“transformation and eventual gastric cancer development are thought to result from a chronic inflammatory condition initiated by Helicobacter pylori infection.(2) The current pathway for gastric cancer development, as proposed by Correa(3) and others,(4) is a progression from inflammation-induced changes in the gastric…”
Background
Metadata
- Authors
- Polk, D. B., & Peek, R. M.
- Affiliations
- University of Southern California (US)
- Vanderbilt University (US)
- Corresponding author
- Peek, Richard M.
- Venue
- Nature Reviews Cancer
- Published
- 2010-06
- Volume
- 10
- Issue
- 6
- Pages
- 403-414
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- PMC
- PMC2957472
- OpenAlex
- W1998630067
- Cited by
- 1,158
- References
- 144
- Citations by year
- 2026: 66 · 2025: 71 · 2024: 74 · 2023: 86 · 2022: 74 · 2021: 80 · 2020: 73 · 2019: 66 · 2018: 72 · 2017: 58 · 2016: 83 · 2015: 68 · 2014: 70 · 2013: 79 · 2012: 72
- FWCI
- 12.04
- Type
- journal article
- Language
- en
- Update notices
- erratum (2010-08-01)
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (R01CA077955, P01CA116087)
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK058587)
- Topics
- Health Sciences › Medicine › Gastroenterology › Helicobacter pylori-related gastroenterology studies
- Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
- Health Sciences › Medicine › Pharmacology (medical) › Inflammatory mediators and NSAID effects
- Keywords
- Helicobacter pylori, gastric adenocarcinoma, inflammatory carcinogenesis, host-microbe interactions, gastritis, gastric microbiota, cancer risk factors, cancer prevention
- MeSH terms
- Animals, Humans, Risk Factors, Stomach Neoplasms, Signal Transduction, Helicobacter pylori, Helicobacter Infections, ErbB Receptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.